ARCHIVES

Kadcyla Extends Median PFS In Open-Label Phase III Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Approves Treatment For Late-Stage Cervical Cancer

June 30, 2006

Study Examines Lung Cancer Among Lifelong Nonsmokers

October 31, 2008

In Brief: Henderson Chairs Reorganized NCA Centers Subcommittee; Core Grant Guidelines On Agenda

August 22, 1980

Analysis Shows No Mortality Benefit From Regular PSA Screening

January 27, 2012

Drug Shortages Reach All-Time High—Ben Venue Exit Will Make Problem Worse

October 11, 2013

Senate Committee Ok’s $1.9 Billion Budget For NCI, Same As House Appropriation

July 29, 1994